According to the TCGA database, the median overall survival time of CESC patients with lower MTL5-mRNA level was 136.2 months, while decreased to 96.3 months in those with higher MTL5-mRNA level (Figure 3(b), p = 0.004). This evidence concerns the gene TESMIN and cervical squamous cell carcinoma.